Davis's Drug Guide
Overview of Risk Evaluation and Mitigation Systems (REMS)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Overview of Risk Evaluation and Mitigation Systems (REMS)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS__.
Vallerand AHA, Sanoski CAC, . Overview of Risk Evaluation and Mitigation Systems (REMS). Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS__. Accessed April 25, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Overview of Risk Evaluation and Mitigation Systems (REMS). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS__
Vallerand AHA, Sanoski CAC, . Overview of Risk Evaluation and Mitigation Systems (REMS) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 April 25]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS__.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Overview of Risk Evaluation and Mitigation Systems (REMS)
ID - 109942
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS__
PB - F.A. Davis Company
ET - 19
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -